- Home
- CUBI vs CLDX Comparison
CUBI vs CLDX Comparison
Compare CUBI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBI
- CLDX
- Stock Information
- Founded
- CUBI 1994
- CLDX N/A
- Country
- CUBI United States
- CLDX United States
- Employees
- CUBI N/A
- CLDX N/A
- Industry
- CUBI Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CUBI Finance
- CLDX Health Care
- Exchange
- CUBI Nasdaq
- CLDX Nasdaq
- Market Cap
- CUBI 1.4B
- CLDX 1.3B
- IPO Year
- CUBI 2012
- CLDX 2008
- Fundamental
- Price
- CUBI $51.98
- CLDX $18.33
- Analyst Decision
- CUBI Buy
- CLDX Buy
- Analyst Count
- CUBI 10
- CLDX 9
- Target Price
- CUBI $65.44
- CLDX $50.00
- AVG Volume (30 Days)
- CUBI 284.9K
- CLDX 707.5K
- Earning Date
- CUBI 04-24-2025
- CLDX 05-08-2025
- Dividend Yield
- CUBI N/A
- CLDX N/A
- EPS Growth
- CUBI N/A
- CLDX N/A
- EPS
- CUBI 3.98
- CLDX N/A
- Revenue
- CUBI $591,500,000.00
- CLDX $7,559,000.00
- Revenue This Year
- CUBI $15.09
- CLDX N/A
- Revenue Next Year
- CUBI $9.29
- CLDX N/A
- P/E Ratio
- CUBI $13.05
- CLDX N/A
- Revenue Growth
- CUBI N/A
- CLDX 24.49
- 52 Week Low
- CUBI $40.75
- CLDX $14.40
- 52 Week High
- CUBI $68.49
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- CUBI 60.04
- CLDX 44.29
- Support Level
- CUBI $49.81
- CLDX $17.85
- Resistance Level
- CUBI $52.26
- CLDX $21.23
- Average True Range (ATR)
- CUBI 1.62
- CLDX 1.12
- MACD
- CUBI 0.50
- CLDX -0.09
- Stochastic Oscillator
- CUBI 96.04
- CLDX 12.87
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.